Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pulmonology

Daily Management and Medication Safety

At a Glance

Safe daily ABPA care means following the exact instructions for steroids and antifungals, monitoring bone health, blood sugar, liver function, and blood pressure, and reviewing all medicines for interactions. Never stop oral steroids suddenly; follow the prescribed taper.

Living with Allergic Bronchopulmonary Aspergillosis (ABPA) requires managing not just the condition itself, but also the powerful medications used to treat it. Because treatment often involves long-term steroids or antifungals, your day-to-day routine will likely include specific steps to monitor for side effects and ensure your medications are working safely and effectively [1][2].

Managing Corticosteroid Side Effects

Systemic steroids (like prednisolone) are effective at calming lung inflammation, but they can affect almost every system in your body when taken for long periods [3].

Protecting Your Bones and Metabolism

  • Bone Health: Long-term steroid use increases the risk of osteoporosis (thinning bones) and fractures [1][4]. Your doctor should perform an individualized fracture-risk assessment, which may include a DEXA scan. Depending on your kidney health and diet, they may prescribe specific bone-protection medicines, or calcium and vitamin D supplements [2][4].
  • Blood Sugar: Steroids can cause your blood sugar to rise, potentially leading to steroid-induced diabetes. You may need regular blood tests (like HbA1c) to monitor how your body processes sugar [3][2].
  • Adrenal Crisis Warning: Never stop taking your oral steroids abruptly. Follow your doctor’s exact tapering schedule. Seek emergency care if you experience severe weakness, vomiting, confusion, or fainting, as these are signs of an adrenal crisis [5].

Navigating Antifungal (Azole) Therapy

Antifungals like itraconazole are “steroid-sparing,” meaning they help you take lower doses of steroids. However, they require careful management to be effective [6][7].

The Importance of Formulation and Food

How you take your antifungal depends entirely on which exact version (formulation) you were prescribed. These formulations are not interchangeable and have completely different absorption rules [8][9]:

  • Conventional Capsules: These usually require a full meal and a certain amount of stomach acid to be absorbed. Taking them with an acidic drink (like cola) can sometimes help [10][11].
  • Liquid (Oral Suspension): These may have different requirements, such as taking them on an empty stomach [10].
  • SUBA-Itraconazole: Has different instructions entirely and is generally taken with food.
  • Avoid Acid-Blockers: Common heartburn medications (like omeprazole or antacids) can significantly reduce how much medicine your body absorbs for certain formulations. Always check with your pharmacist before starting or stopping any stomach medication [11][10].

Critical Drug Interactions

Antifungals can act like a “magnifying glass” for other drugs, making them stay in your system much longer and at higher levels than intended [5][12].

The “Steroid Multiplier” Effect

Itraconazole can block the way your body breaks down inhaled corticosteroids (like fluticasone or budesonide). This can lead to a surprising situation where a patient using only an inhaler develops Cushing’s syndrome or adrenal suppression (where the body stops making its own natural cortisol) [13][5].

Interactions for Cystic Fibrosis (CF) Patients

If you have CF and are taking CFTR modulators (like Trikafta/Kaftrio or Symdeko/Symkevi), it is vital to coordinate with your CF specialist. Antifungals can significantly change the levels of these modulators in your blood, often requiring a strict dose reduction of your CF medication to prevent toxicity [14][15].

A Checklist for Daily Wellness

  • Monitor for Jaundice: Since antifungals can affect the liver, watch for yellowing of the skin or eyes, dark urine, or unusual fatigue [4][2].
  • Check Blood Pressure: Some newer antifungals (like posaconazole) can cause high blood pressure or changes in your electrolytes [16].
  • Maintain Underlying Care: Ensure you are consistently taking your prescribed inhalers, completing airway clearance, and avoiding smoking/vaping to protect your baseline lung function [17][18].

Common questions in this guide

How should I take itraconazole for ABPA?
Itraconazole instructions depend on the formulation. Conventional capsules are usually taken with a full meal, some liquid suspensions are taken on an empty stomach, and SUBA-itraconazole is generally taken with food. These forms are not interchangeable, so follow your prescription label and ask your pharmacist if you are unsure.
Can I take antacids or omeprazole with itraconazole?
Acid-blocking medicines and antacids can reduce absorption of some itraconazole formulations. Check with your pharmacist before starting, stopping, or changing an antacid, omeprazole, or other stomach medicine.
Why should I avoid stopping prednisolone suddenly?
Long-term oral steroids can reduce the body's natural cortisol production, so stopping them abruptly can cause a dangerous adrenal crisis. Follow the prescribed taper, and seek emergency care for severe weakness, vomiting, confusion, or fainting.
What monitoring is needed when I take steroids long term for ABPA?
Long-term steroids can weaken bones and raise blood sugar. Your clinician may assess fracture risk, arrange bone-density testing such as a DEXA scan, recommend calcium or vitamin D, and use blood tests such as HbA1c to monitor sugar levels.
Can ABPA antifungals interact with inhaled steroids or CF medicines?
Yes. Itraconazole and other azole antifungals can raise levels of some inhaled steroids, which may cause Cushing-like changes or suppress natural cortisol production. They can also change levels of CFTR modulators, so a CF specialist may need to adjust the dose.
What warning signs should I watch for while taking an ABPA antifungal?
Contact your healthcare team about yellow skin or eyes, dark urine, or unusual fatigue, which can signal a liver problem. If you take posaconazole, blood-pressure and electrolyte monitoring may also be needed. Seek urgent help for severe or rapidly worsening symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Should I have a baseline DEXA scan to check my bone density, and how often should we repeat it?
  2. 2.Can we review all my medications (including inhaled steroids and CFTR modulators) to ensure there are no dangerous interactions with my antifungal?
  3. 3.When should I check my blood sugar or HbA1c to monitor for steroid-induced diabetes?
  4. 4.If I am on itraconazole, what is the best way for me to take it—with a full meal, an acidic drink, or on an empty stomach?
  5. 5.What are the signs of adrenal suppression I should look for if we are tapering my steroids?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.

    Tolebeyan A, Mohammadi O, Vaezi Z, Amini A

    Cureus 2020; (12(8)):e9684 doi:10.7759/cureus.9684.

    PMID: 32923277
  2. 2

    Pharmacist-Led Full-Course Pharmaceutical Care Model in Allergic Bronchopulmonary Aspergillosis: A Case Report-Based Approach to Optimizing Multidisciplinary Management.

    Huang X, Zheng Y, Jin X, et al.

    Infection and drug resistance 2026; (19()):565067 doi:10.2147/IDR.S565067.

    PMID: 41868025
  3. 3

    Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.

    Eldaabossi SAM, Awad A, Anshasi N

    Respiratory medicine case reports 2021; (34()):101520 doi:10.1016/j.rmcr.2021.101520.

    PMID: 34692397
  4. 4

    Case Report: Allergic Bronchopulmonary Aspergillosis Revealing Asthma.

    Snen H, Kallel A, Blibech H, et al.

    Frontiers in immunology 2021; (12()):695954 doi:10.3389/fimmu.2021.695954.

    PMID: 34239516
  5. 5

    Acute Invasive Pulmonary Aspergillosis Complicating Allergic Bronchopulmonary Aspergillosis: Case Report and Systematic Review.

    Maturu VN, Agarwal R

    Mycopathologia 2015; (180(3-4)):209-15 doi:10.1007/s11046-015-9907-0.

    PMID: 26045286
  6. 6

    Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.

    Agarwal R, Sehgal IS, Muthu V, et al.

    The European respiratory journal 2024; (63(4)) doi:10.1183/13993003.00061-2024.

    PMID: 38423624
  7. 7

    [Allergic bronchopullmonary aspergillosis (ABPA) - an Update].

    Joest M, Klein J, Kütting D, Skowasch D

    Pneumologie (Stuttgart, Germany) 2024; (78(3)):204-214 doi:10.1055/a-1854-3006.

    PMID: 38417459
  8. 8

    SUBA-itraconazole in the treatment of systemic fungal infections.

    Liu J, Vanderwyk KA, Donnelley MA, Thompson Iii GR

    Future microbiology 2024; (19(13)):1171-1175 doi:10.1080/17460913.2024.2362128.

    PMID: 39011995
  9. 9

    Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.

    Abbotsford J, Foley DA, Goff Z, et al.

    The Journal of antimicrobial chemotherapy 2021; (76(1)):249-252 doi:10.1093/jac/dkaa382.

    PMID: 32929460
  10. 10

    The Impact of Dietary Interventions on the Pharmacokinetics of Antifungal Drugs: A Systematic Review with Meta-analyses.

    Wiesner-Kiełczewska A, Zagrodzki P, Paśko P

    Clinical pharmacokinetics 2025; (64(6)):815-848 doi:10.1007/s40262-025-01511-6.

    PMID: 40347349
  11. 11

    Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers.

    Abuhelwa AY, Mudge S, Upton RN, Foster DJR

    European journal of drug metabolism and pharmacokinetics 2019; (44(2)):201-215 doi:10.1007/s13318-018-0519-1.

    PMID: 30328059
  12. 12

    The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles.

    Czyrski A, Resztak M, Świderski P, et al.

    Pharmaceutics 2021; (13(11)) doi:10.3390/pharmaceutics13111961.

    PMID: 34834376
  13. 13

    Iatrogenic Cushing's syndrome in a case of allergic bronchopulmonary aspergillosis treated with oral itraconazole and inhaled budesonide.

    Garg VK, Tickoo V, Prasad VP, Maturu VN

    BMJ case reports 2023; (16(10)) doi:10.1136/bcr-2023-256788.

    PMID: 37813554
  14. 14

    Subtherapeutic triazole concentrations as result of a drug-drug interaction with lumacaftor/ivacaftor.

    Smeets TJL, van der Sijs H, Janssens HM, et al.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2024; (23(3)):563-565 doi:10.1016/j.jcf.2024.01.006.

    PMID: 38281825
  15. 15

    Mepolizumab use in cystic fibrosis-associated allergic bronchopulmonary aspergillosis.

    Boyle M, Mulrennan S, Morey S, et al.

    Respirology case reports 2021; (9(1)):e00696 doi:10.1002/rcr2.696.

    PMID: 33304594
  16. 16

    Posaconazole-induced hypertension in children with cystic fibrosis.

    Marpole R, Yeoh DK, Withers AL

    Respirology case reports 2021; (9(9)):e0822 doi:10.1002/rcr2.822.

    PMID: 34377495
  17. 17

    Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis.

    Gothe F, Schmautz A, Häusler K, et al.

    The journal of allergy and clinical immunology. In practice 2020; (8(8)):2608-2614.e3 doi:10.1016/j.jaip.2020.02.031.

    PMID: 32147521
  18. 18

    Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.

    McCreary EK, Davis MR, Narayanan N, et al.

    Pharmacotherapy 2023; (43(10)):1043-1050 doi:10.1002/phar.2850.

    PMID: 37459118

This page is for informational purposes only and does not constitute medical advice about ABPA. Ask your prescriber or pharmacist before changing steroids, antifungals, inhalers, or other medicines.

Get notified when new evidence is published on Allergic bronchopulmonary aspergillosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.